News

MedImmune’s Antibody Therapy Seen to Effectively Reduce Cancer Stem Cells in Most Newly Diagnosed Multiple Myeloma Patients

A research team led by William Matsui, MD, and Carol Ann Huff, MD, with the Johns Hopkins Kimmel Cancer Center, has found that MedImmune’s novel MEDI-551 antibody treatment effectively decreased the number of cancer stem cells, which drive the growth of cancer, in most patients with recently diagnosed multiple myeloma. Study results will be…

Documentary on Myeloma Supporters Who Climbed Kilimanjaro Premiered in Miami

Advocates working to raise awareness and funds for multiple myeloma successfully climbed Mount Kilimanjaro, and a documentary about the climb premiered last month at the Eden Roc Miami. The group included 15 multiple myeloma patients, doctors, family members, and supporters. The climb took place in January and raised about $250,000 for the disease.

First Large-Scale Screening Aims to Prevent Myeloma Before Onset

A screening study — the largest of its kind for myeloma — hopes to find a way to prevent myeloma before it develops. The study, called iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma), was announced by the International Myeloma Foundation (IMF), which is funding the research. The organization is the largest…